| Old Articles: <Older 11711-11720 Newer> |
 |
The Motley Fool January 17, 2006 Seth Jayson |
Blast From the Past With earnings and a lockup on the horizon, Hoku Scientific stock is reaching a crossroads.  |
The Motley Fool January 17, 2006 Tim Beyers |
Who's Buying Now? Sometimes insiders are buying for all the right reasons. Who's at it this week? Cabot Corp... Chesapeake Energy... Hearst-Argyle Television... Joseph A. Bank Clothiers... Sirius Satellite Radio...  |
The Motley Fool January 17, 2006 Seth Jayson |
Dive Into MarineMax? Is the nation's largest boat-dealer network going to float? Interested investors should keep a careful eye on the integration of acquisitions.  |
The Motley Fool January 17, 2006 Stephen D. Simpson |
High-Stakes Medical Device Chicken Boston Scientific has upped the ante again. Are they bluffing? Their latest offer is $80 a share -- $42 in cash and $38 in stock. Let's hope the board knows what it is doing, because it is staking the company on this.  |
The Motley Fool January 17, 2006 Stephen D. Simpson |
Fifth Third: Still Waiting There are some signs of progress at the regional bank, but a full turnaround isn't yet in the works. As long as the company isn't doing permanent damage to its customer base, there could still be a second act here. Investors, take note.  |
The Motley Fool January 17, 2006 Rick Aristotle Munarriz |
Restoration's Hard Wear The trendy home-decor specialist plays the blame game as it gears up to post yet another annual loss. Investors, take note.  |
The Motley Fool January 17, 2006 Rich Smith |
Foolish Forecast: Relax With Ethan Allen Not all furniture makers are struggling. Even better for its investors, analysts have again set the bar low for Ethan Allen tomorrow.  |
The Motley Fool January 17, 2006 Bill Barker |
When the "Top 25" Meets the "Top 12" Investors will do well reading Joel Greenblatt's The Little Book That Beats the Market and using his free formula to identify likely market-beating stocks.  |
The Motley Fool January 17, 2006 Stephen D. Simpson |
Growth, at a Cost, for Commerce Bancorp Loan and deposit growth is torrid, but so is growth in expenses. Investors, take note.  |
The Motley Fool January 17, 2006 Stephen D. Simpson |
Forest Labs: Is Different Better? Forest isn't your typical pharmaceutical company, and that's both its boon and its bane for investors.  |
| <Older 11711-11720 Newer> Return to current articles. |